Patients With Low-Grade Non-Hodgkin's Lymphoma Previously Treated With Tositumomab and/or Iodine I 131 Tositumomab

Clinical trial NCT00240591 · COMPLETED

Trial details

NCT number: NCT00240591
Sponsor: GlaxoSmithKline
Status: COMPLETED
Study type: OBSERVATIONAL

Lymphoma, Non-Hodgkin

Start date: 2003-10-01
Primary completion: 2010-06-01
Enrollment: 150

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.